6 Abbreviations used in this paper: Dok, Downstream of tyrosine kinase; PH, pleckstrin homology; PTB, phosphotyrosine-binding.
Introduction
Adaptor molecules are proteins containing modular binding domains that are devoid of intrinsic enzymatic activity, but that serve as essential scaffolds for the formation of multimolecular signaling complexes in a variety of cell lineages, notably in T cells (1) . Dok 6 proteins are a growing family of adaptor molecules, containing an amino-terminal pleckstrinhomology (PH) domain, a central phosphotyrosine binding (PTB) domain and a carboxyterminal part with several tyrosine phosphorylation sites leading to interactions with SH2 domains. The role of the first two identified Dok family members : Dok-1 and Dok-2, has been assessed in the T cell lineage (2) . These proteins are tyrosine phosphorylated upon TCR triggering or the engagement of the costimulatory molecules (3) (4) (5) . They are potent inhibitors of T cell activation via their binding to RasGAP, which regulates Ras activation, but also probably via their association with Src and Tec protein tyrosine kinases (PTKs) family members (6, 7) .
Overexpression studies involving Dok-1 or Dok-2 molecules provided evidence that these adapter proteins inhibit PLCγ-1 and Ras-ERK/MAPK (extracellular signal-regulated kinase / mitogen-activated protein kinase) signals and can prevent IL-2 promoter activation (4, 7).
Knockdown of Dok-1 and Dok-2 in human primary T cells reveals their negative role on T cell functions (3) . Upon TCR triggering, T cells from mice lacking both Dok-1 and Dok-2 displayed increased IL-2 production, as well as proliferation (8) .
Additional five members of this Dok-related family have been identified and named from Dok-3 to Dok-7 (9) (10) (11) (12) (13) (14) (15) (16) . Among these members, only the gene encoding for Dok-4 is expressed in resting T cells (14) . Based on analysis of phylogenetic trees and exon/intron structure of Dok family members, Dok-4 is part of a group that is distinct from that including Dok-1 and Dok-2. In non-immune cells, Dok-4 appears to be a substrate of c-Ret or insulin receptor tyrosine kinase and Src protein tyrosine kinase family members (11, 12) . Functional
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studies of Dok-4 have yielded conflicting results with two reports claiming that it enhanced Ret or insulin receptor-mediated ERK activation (11, 12) and one other report finding that it inhibited Ret and Src PTKs-mediated activation of the ERK substrate: Elk-1 (13) . These apparent discrepancies may relate to differences in cell types, stimuli, and readouts used in the various studies. In Ret signalling, Dok-4 leads to activation of the small G protein Rap1, which induces a sustained activation of ERK in nerve cells (17) . Therefore, it would be useful to extend the studies of Dok-4 to other cell types that expressed it, including T cells, where its function remains unknown. Here, we investigated if Dok-4 could be a substrate of the PTKs involved during T cell activation. We report that Dok-4 accumulates in an intracellular vesicular compartment that is recruited to the polarized MTOC (microtubule organising centre) during T cell activation and that it requires its PH domain to adopt this particular localization. The PH domain was also necessary for Dok-4 ability to inhibit ERK activation and IL-2 promoter activity in T cells.

Material and Methods
Culture cells and transfection
Jurkat JA16 T cell subclone and Raji B cell lymphoma were grown in RPMI 1640 medium supplemented with 10 % fetal calf serum, 2 mM L-glutamine, and 1 mM sodium-pyruvate. L cells expressing human B7.1 (B7.1 L cells) were cultured in Dulbecco's modified Eagle's medium supplemented with 10 % fetal calf serum, 2 mM L-glutamine and 1 mM sodiumpyruvate (18) . Hut-78 T cells were grown in RPMI 1640 medium supplemented with 10 % fetal calf serum (3).
PBMC from healthy donors (Etablissement Français du Sang, Marseille, France) were isolated on Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) gradients before purification of the CD4 + T cell subset using the naïve CD4 + T cell isolation kit (Miltenyi Biotec, Paris, France).
Plasmid constructs
The construct βDNA4HADok-4 (Dok-4) corresponding to the wild-type full-length human Dok-4 cDNA tagged with HA epitope in the 5' end, was generated by subcloning of pGEM-T easy vector containing HA tagged Dok-4, described previously (14) , into the βDNA4 vector, using the restriction site NotI. The βDNA4 vector corresponds to the pCDNA3 vector (Invitrogen, Cergy Pontoise, France) where its promoter region has been replaced by the promoter region of chicken β-actin (7). Expression plasmid βDNA4HA-ΔPHDok-4
(ΔPHDok-4), containing the human Dok-4 cDNA tagged with HA epitope in the 5' end lacking the PH domain (deletion of aa 1-119), was generated by PCR amplification of βDNA4HADok-4 using the following primers: sense primer 5'-atgtacccatacgacgtcccagactacgctagtctgggagaacctgacctc-3' (containing HA epitope), antisense primer 5'-tcactgggatggggtcttggcctcac-3'.
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Green Fluorescence Protein (GFP) fusion protein expression vectors, Dok4-GFP and ΔPHDok4-GFP were obtained by removing HA epitope and stop codon from βDNA4HADok-4 and βDNA4HA-ΔPHDok-4 respectively, and introducing cDNAs into the BamHI/KpnI sites of the pEGFP-N1 vector (Clontech, Palo Alto, CA).
The PH domain tagged GFP (PHDok4-GFP) (aa 1-122) was amplified from βDNA4HADok-4 with the following primers: sense primer 5'-ccgaattccatggcgaccaatttcagtg-3' and antisense primer 5'-cggtggatcccgtcccagactgatgtcgttga-3'. The PCR product was subcloned into BamHI/KpnI sites of pEGFP-N1 expression vector. The expression vector Dok4PTB*-GFP encodes for a Dok4 -GFP fusion protein containing point mutations into the PTB domain of Dok-4, corresponding to the substitution of Arginine 185 and 186 in Alanine (R185/186A). These mutations were previously described for Dok-1 (19) . They were obtained using QuickChange® system (Stratagene, Amsterdam, NL) as from the Dok4-GFP expression vector, with the following primers sense 5'-ccctctgctcactggccgcctatggccggg-3' and antisense 5'-gcatcccggccataggcggccagtgagcag-3' (corresponding mutations R185/186A are underlined).
The expression vector Dok1-GFP encoding for a Dok1-GFP fusion protein was generated by PCR amplification from βDNA4HADok-1 using the following primers: sense 5'-agatctcgagctatggacggggctgtgatggag-3' and anti-sense 5'-ggtcaagtctgagggttccaccgtcgacggtaccgcg-3'. The PCR products were sequenced and cloned in pEGFP-N1 XhoI/KpnI.
The promoter assay plasmids pIL-2-Luc composed of IL-2 promoter, fused to firefly luciferase reporter gene and pβ-actin-Rluc composed of β-actin promoter, fused with Renilla luciferase gene were previously reported (20) .
For siRNA, the pH1shDNA plasmids were derived from the pH1-XhoI plasmid (a descendant of pBlueScript KS+) and contained a XhoI-flanked fragment containing the human H1
promoter amplified by PCR from human blood mononuclear cell genomic DNA, the template 
Antibodies and products
CD3 mAbs 289, OKT3 and CD28 mAb 248 have been already reported (18) . Polyclonal antiDok1 antibodies have been described previously (20) . Anti-Dok2 mAb was purchased from BD Transduction laboratory (Le-Pont-De-Claix, France). Polyclonal anti-Dok4 antibodies used in western blot experiments were purchased from Abgent (San Diego, CA) or described previously (13) . Polyclonal anti-Dok4 antibodies used in immunoprecipitation experiments were described previously (13 After stimulation, the cells were deposed onto poly-L-lysine coated coverslips, let sediment for 3 min, and then centrifugated at 300 rpm for 1 min. The conjugates were fixed for 5 min in 
Stimulation and cell lysis
Jurkat cells (10.10 6 ) were stimulated at 37°C in RPMI 50mM Hepes. Stimulations were carried out for the indicated times with Raji cells (ratio 2:1) pulsed or not for 20 min at 37°C
with SEE at 5µg/ml, CD3 mAb 289 at 10µg/ml, CD28 mAb CD28. 
Immunoprecipitation and western blotting
For immunoprecipitation, lysates were clarified and incubated with purified anti-GFP or antiDok4 polyclonal antibodies coupled to protein A-Sepharose, for 2 h at 4 °C.
Immunoprecipitates were washed two times in 1 ml of lysis buffer and then boiled in reducing SDS gel sample buffer for 5 min. Samples were resolved by standard 10% SDSpolyacrylamide gels. 
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Rap assays
Rap activity was determined as described previously using a GST-RalGDS-RBD fusion protein (22) . Briefly, Jurkat cells (10 x 10 6 ) were stimulated as indicated with 10 μg/ml CD3 mAb (289), lysed in standard NP40 buffer and clarified by centrifugation at maximal speed in an Eppendorf centrifuge for 10 min at 4°C. Two μg of purified GST-RalGDS-RBD coupled to glutathione-sepharose beads were added to the supernatant and incubated at 4°C for 60 min. Beads were washed four times in lysis buffer and denaturated with SDS.
Luciferase assays
Jurkat cells ( 
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Results
Expression and intracellular localization of Dok-4 proteins in T cells
We have previously reported DOK4 gene expression in resting T cells (14) . An anti-Dok4 polyclonal antiserum (see "Materials and Methods") was produced to determine the levels of Dok-4 protein in cells including T cells. COS cells transiently transfected or not with an expression vector containing the Dok-4 cDNA demonstrated the specificity of this antibody.
As shown in Fig. 1A , strong expression of a 37 kDa protein, consistent with the expected MW of Dok-4, was detected in lysates from Dok4-transfected compared to control COS cells. The weak signal detected in non-transfected COS-7 cells was thought to correspond to endogenous Dok-4 expression, which had been previously reported in several epithelial cell lines (13) . Dok-4 protein was also detected in peripheral blood T cells (PBL-T) and in the Jurkat T cell line confirming previous mRNA expression data (14) . To determine the subcellular localization of Dok-4 in T cells, three different fractions of Jurkat T cell lysates corresponding to cytosol, membranes or cytoskeleton, were analyzed by anti-Dok4 immunoblotting (Fig. 1B, top panel) . Endogenous Dok-4 was detected only in the cytosol and cytoskeleton fractions and was absent from membranes. This distribution pattern paralleled that of actin, vimentin and α /γ-tubulin that are present in both cytoskeleton and cytosol fractions (data not shown). Unfortunately, using different polyclonal anti-Dok4 antibodies, we
were not able to detect the endogenous Dok-4 protein in T cells by confocal microscopy. To determine the intracellular localization of Dok-4, we produced a Dok4-GFP fusion protein, which we expressed in Jurkat T cells. Anti-GFP immunoblots confirmed that the transiently expressed Dok4-GFP was largely contained in the cytosol and in the cytoskeleton fractions like the endogenous protein (Fig. 1B, top versus bottom panel) . Under confocal microscopy, Dok4-GFP was primarily localized in a condensed area of Jurkat T cell cytoplasm (Fig. 1C) .
Since Dok-4 contains a PH domain that might be recruited by phosphoinositides, localization
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experiments were duplicated in a T cell line with a normal phosphatidylinositol 3-kinase (PI3K) activation, Hut-78. Consistent with the previously reported insensitivity of the Dok-4 PH domain to the activation of PI3K (23), a similar distribution of Dok4-GFP was observed in both Jurkat and Hut-78 T cells (Fig. 1C) . Notably, the level of Dok4-GFP overexpression in these experiments was moderate, as documented by comparison of the 62 kDa Dok4-GFP fusion protein versus the 37 kDa endogenous Dok-4 signal, on the same immunoblot (Fig.   1D ). These observations confirm that Dok-4 is expressed in specific compartments in T cells, prompting further investigation into the effect of T cell activation upon Dok-4.
Dok-4 is tyrosine phosphorylated upon TCR stimulation
Other members of Dok family such as Dok-1 are substrates of protein tyrosine kinases (PTKs) in T cells (4, 7, 24) . In Jurkat T cells, Dok-1 is prominently tyrosine phosphorylated upon engagement of CD28 by its B7-1 (CD80) ligand, but poorly phosphorylated upon TCR stimulation with CD3 mAbs (25) . Therefore, we examined the tyrosine phosphorylation state of Dok-4 under TCR or CD28 stimulation. Jurkat cells were stimulated with CD3 mAbs or with L cells expressing B7-1 ligand. Lysates obtained from these cells were subjected to immunoprecipitation with anti-Dok4 ( Fig. 2A, top panels) or anti-Dok1 ( Fig. 2A , bottom panels) antibodies followed by anti-phosphotyrosine immunoblotting. As previously described, Dok-1 was more prominently phosphorylated upon CD28 stimulation than TCR stimulation ( Fig. 2A, bottom panels) . In contrast, Dok-4 was tyrosine phosphorylated only when the TCR/CD3 complex was stimulated, though detection of this phosphorylation proteins was detectable in unstimulated Jurkat cells (Fig. 2B) . As previously described (25) , tyrosine phosphorylation of Dok-1 increased more prominently in Jurkat T cells in the absence than in the presence of a TCR stimulus (Fig. 2B, bottom panels) . In contrast to Dok-1, tyrosine phosphorylation of Dok-4 was most strongly increased upon presentation of SEE by Raji B cells (Fig. 2B, top panels) . Dok-4 phosphorylation was still detectable after 20 min of contact with SEE-pulsed Raji B cells (supplementary Fig. 2 ). Thus, these data suggest that the Dok-4 protein is phosphorylated upon TCR engagement.
Dok-4 relocates to the T cell MTOC during APC contact.
Several intracytoplasmic PTK substrates are recruited to the T cell plasma membrane in the context of a T cell -APC contact (26, 27) . The cell contact zone has been termed the "Immunological Synapse" (IS) (28) . To determine whether Dok-4 is recruited to the IS, we analyzed by confocal microscopy, cell contacts between Jurkat T cells expressing Dok4-GFP and SEE-pulsed Raji B cells labelled in red with a celltracker dye (Fig. 3A) . Twenty minutes after contact, Dok-4 protein was located in an intracytoplasmic compartment opposite to the IS. More prolonged contacts (45 min) resulted in the relocalization of Dok-4 in close proximity to the IS. This change in Dok-4 localization did not occur in the absence of antigen, suggesting that it was induced by TCR stimulation. This late distribution pattern evoked similarities with a polarized MTOC, which has been described before in this position (29) . To determine whether Dok-4 was located within the MTOC, the centrosomal protein γ-tubulin, a key factor in microtubule nucleation, was used as a marker (30) . In support of Dok-4 localization in the MTOC, we found that, in cell fractionation experiments, Dok-4 and γ-tubulin presented the same distribution pattern (Fig. 3B) . To confirm this, confocal analysis
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was performed in cell conjugates formed between Dok4-GFP-transfected Jurkat T cells and SEE-pulsed Raji B cells. In unstimulated T cells, γ-tubulin was condensed in a cytoplasmic dot-like structure typical of a MTOC, whereas Dok-4 was in a distinct compartment in close proximity to the MTOC (Fig. 3C, top panels) . Upon contact with SEE-pulsed Raji B cells (time of contact: 20 -45 min), a polarized MTOC was detected in the vicinity of the IS on both T cell and APC side (Fig. 3C , middle and bottom panels). During the early phase of cell contact formation, Dok-4 was preferentially found opposite to the IS and MTOC in a membrane or sub-membrane compartment (Fig. 3C, middle panels) . Later on, Dok-4 relocalized within the MTOC itself (Fig. 3C , bottom panels). Upon synapse formation, tyrosine phosphorylation of Dok-4 was consistently detectable until Dok-4 joined the polarized MTOC, at which point Dok-4 was no longer phosphorylated (supplementary Fig. 2 & Fig.   3D ). These results indicate that Dok-4 is specifically shuttled during T cell activation, being first excluded from the IS, but then moving back to its vicinity into the polarized MTOC after a phase of transient recruitment at the plasma membrane ( Fig. 3C & Fig. 3D ). Nocodazole treatment (a microtubule-disrupting drug) confirmed that Dok-4 migration to the vicinity of the IS was dependent upon microtubule network formation (supplementary Fig. 3 ).
The PH domain regulates Dok-4 localization in T cells
Dok-4 contains two protein:protein interaction domains, the PH and PTB domains (11, 12, 14) . Both domains are important for Dok-4 plasma membrane localization in epithelial cells (13) . To test the role of these domains on Dok-4 localization in T cells, we generated different mutants of Dok-4 fused to GFP, lacking either the PH domain (ΔPHDok4-GFP) or the PTB and the carboxy terminal part (PHDok4-GFP). We also developed a PTB mutant of Dok-4 containing a substitution of critical residues of the PTB domain (Dok4PTB* -GFP), these arginine to alanine mutations are usually able to abolish the binding functions of the PTB inserm-00374930, version 1 -10 Apr 2009
domains as described for the PTB domain of Dok-1 (19) . The localization of the different Dok-4 mutants in unstimulated Jurkat T cells or in contact with SEE-pulsed Raji B cells, was determined by confocal microscopy. Deletion of the PH domain  ΔPHDok4-GFP) resulted in a diffuse cytosolic distribution in stimulated or unstimulated Jurkat cells (Fig. 3D, top panels) .
The isolated PH domain of Dok-4 (PHDok4-GFP) was localized in a cytosolic and membrane fraction, and was not recruited to the MTOC during IS formation (Fig. 3D, middle panels) .
Point mutations in the PTB domain (Dok4PTB* -GFP) did not alter the distribution of Dok4 (Fig. 3D, bottom panels) . These results indicate that the PH domain of Dok4 is necessary for the basal localization of Dok4, and for its recruitment in the MTOC compartment during T cell / APC junction.
Dok-4 regulates T cell signaling
To determine the role of the Dok-4 molecule in signaling events downstream of TCR stimulation, we analyzed ERK1/2 activation in Jurkat cells upon contact with SEE-pulsed Raji B cells. Different research groups reported that Dok-4 was involved in ERK activation and downstream transcription factors such as Elk-1 (11) (12) (13) 17) . However studies found Dok-4 to be an activator of ERK pathway in CHO cells or nerve cells (11, 12, 17) and other studies found that Dok-4 inhibited the activation of Elk-1 in Caco-2 epithelial cells (13, 31) . To resolve this issue in T cells, we developed an alternative approach to knock down Dok4 expression using RNA interference (RNAi). As shown in 
Dok-4 inhibits T cell function
To further determine the role of Dok-4 on T cell activation, we examined IL-2 promoter activation. We had previously shown that SEE-pulsed Raji B cells induced Jurkat cells to transcribe a reporter luciferase gene under the control of an IL-2 promoter sequence (33). In
RNAi-treated Jurkat cells, a decrease of approximately 90% in Dok-4 protein expression was achieved (Fig. 6A , right panels) and was accompanied by increased activity of the IL-2 promoter upon contact with SEE-pulsed Raji B cells (Fig. 6A, left panel) . These results were consistent with the observed effect of Dok-4 RNAi on ERK activation ( Fig. 4B and 4C ).
Conversely, overexpressing Dok-4 in Jurkat cells (Fig. 6B ) reduced IL-2 promoter activity induced by CD3+CD28 co-stimulation. However, Dok-4 overexpression had no impact on IL-2 promoter activity induced by a stimulus (PMA + Ionomycin treatment) that bypasses the early steps in TCR signaling. In contrast to wild-type Dok-4, overexpression of the PHdeleted mutant of Dok4 did not inhibit IL-2 promoter activation (Fig. 6B, left panel) . Anti-HA epitope tag immunoblotting confirmed that similar levels of wild-type Dok-4 (HADok4) and PH-deleted mutant (HAΔPHDok4) were obtained (data not shown). Therefore, deletion of the PH domain abolished the repressive action of Dok-4 on IL-2 promoter activity.
Primary CD4 + PBL-T cells isolated from human peripheral blood were also examined. Dok-4 siRNA sequences were introduced in these cells by nucleofection technology, resulting in an approximately 60% reduction in Dok-4 expression after 24 hours (Fig. 6C, right panel) . Dok-4 inhibition resulted in an increase of CD69 cell surface expression (Fig. 6C, left panel) and of T cell proliferation (Fig. 6D ) in response to CD3+CD28 co-stimulation. Altogether, results
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Discussion In this report, we demonstrate that a novel Dok family member Dok-4, is expressed in specific cytoplasmic compartments in T cells, is phosphorylated in response to TCR engagement and negatively regulates T cell activation.
Having previously shown that Dok-4 mRNA is expressed in resting T cells (14), we have now confirmed that Dok-4 protein is expressed in these cells and that it undergoes tyrosine phosphorylation upon TCR stimulation ( Fig. 2 and supplementary Fig. 1 ). Of note, as compared to phosphorylation of Dok-1 and 2, which is quite robust following T cell stimulation (3), tyrosine phosphorylation of Dok-4 was more subtle and was consistently more difficult to detect. In Dok-1 and Dok-2, most sites of tyrosine phosphorylation appear to be contained within the C-terminal region. In contrast, most tyrosine residues within the Cterminal region of Dok-4 sequence are predicted to be poor substrates for PTKs (data not shown). Indeed, the deletion of this C-terminal region did not alter the tyrosine phosphorylation of Dok-4, suggesting that some tyrosine residues in the PH or PTB domain are accessible to the PTKs (13) . Among the PTKs so far shown to phosphorylate Dok-4 (11-13), only members of the Src family, such as Fyn, are involved in TCR signaling events.
Subcellular localization might be a limiting factor for tyrosine phosphorylation of Dok-4 in T cells. Dok-4 was primarily located at the vicinity of the MTOC, as identified by γ-tubulin staining (Fig. 3C ). Both γ-tubulin and endogenous Dok-4 accumulated in cytoskeletal fractions (Fig. 3B) . Following SAg presentation, Dok-4 was initially located at the distal pole of the immunological synapse. Later on, Dok-4 accumulated at the polarized MTOC in the vicinity of the immunological synapse (Fig. 3) . Dok-4 was also transiently detected at the plasma membrane (Fig. 3C) , which could permit the phosphorylation of Dok-4 by the Src kinase members present in the inner leaflet of the plasma membrane (supplementary Fig. 2 ).
However, the exact identity of the subcellular compartments containing the Dok-4 adaptor molecule remains under investigation.
Following a prolonged cell contact, Dok-4 was located at the polarized MTOC (Fig. 3C ).
Several signaling molecules involved in T cell activation, such as protein kinases (like PKCβ, FAK, or Pyk-2) colocalize with the MTOC (34, 35) . To address the mechanisms responsible for targeting Dok-4 to these intracellular compartments, we examined the role of its PH domain. PH domains are generally considered as phosphoinositide-binding modules and have often been implicated in recruitment of proteins to the plasma membrane (36) . Some molecules like the four-phosphate-adaptor protein 1 and 2 (FAPP1 and FAPP2) accumulate via their PH domains in intracellular compartments such as the trans-Golgi network (37) . The PH domain of Dok-4 is important to localize Dok-4 at the plasma membrane of the epithelial cells (13) . Here, we show that, in T cells, Dok-4 localizes to a unique intracellular compartment through the action of its PH domain (Fig. 3D) . However, an isolated Dok-4 PH domain alone could not accumulate in the same intracellular compartments, suggesting that cooperation with another region of Dok-4 is required. This is not surprising given evidence that other PH domains require the cooperative action of another domain for subcellular targeting (38) (39) (40) . Indeed, Dok-4 itself requires both its PH and PTB domains in order to localize at the membrane in epithelial cells (13) . However, using a point mutant of the PTB domain, we show that the localization of Dok-4 to its unique intracellular compartment in T cells appears to be independent of PTB domain function (Fig. 3E) . Since specific phosphoinositides control the correct location and timing of many trafficking events (41) and since PH domains are generally recognizing a variety of phosphoinositides (42) , defining the phosphoinositide-binding specificity of the Dok-4 PH domain will be important in order to identify its role mediating subcellular targeting of Dok-4.
Our studies show that, in addition to its role in subcellular targeting, the PH domain is also essential to mediate the inhibitory effect of Dok-4 on T cell activation. It has previously been suggested that Dok-4 regulates the ERK signaling pathway (11) (12) (13) 
